These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Prognostic stratification of survivors of lst myocardial infarction: evaluation of regional kinetics and ejection fraction by bidimensional echocardiography]. Catania G; Bruni A; Bridda A; Cargnel G; Sardina G; Soravia G; Carlini A G Ital Cardiol; 1990 Feb; 20(2):133-43. PubMed ID: 2328867 [TBL] [Abstract][Full Text] [Related]
25. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction. Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659 [TBL] [Abstract][Full Text] [Related]
26. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. Yoshida K; Gould KL J Am Coll Cardiol; 1993 Oct; 22(4):984-97. PubMed ID: 8409073 [TBL] [Abstract][Full Text] [Related]
27. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation. Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875 [TBL] [Abstract][Full Text] [Related]
28. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials. Cerqueira MD; Maynard C; Ritchie JL; Davis KB; Kennedy JW J Am Coll Cardiol; 1992 Dec; 20(7):1452-9. PubMed ID: 1452917 [TBL] [Abstract][Full Text] [Related]
29. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. Zaret BL; Wackers FJ; Terrin ML; Forman SA; Williams DO; Knatterud GL; Braunwald E J Am Coll Cardiol; 1995 Jul; 26(1):73-9. PubMed ID: 7797778 [TBL] [Abstract][Full Text] [Related]
30. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Singh BN Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400 [TBL] [Abstract][Full Text] [Related]
31. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Olson PJ; Woelfel A; Simpson RJ; Foster JR Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761 [TBL] [Abstract][Full Text] [Related]
32. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Klein H; Auricchio A; Reek S; Geller C Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848 [TBL] [Abstract][Full Text] [Related]
33. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Pfisterer ME; Kiowski W; Brunner H; Burckhardt D; Burkart F Circulation; 1993 Feb; 87(2):309-11. PubMed ID: 8425280 [TBL] [Abstract][Full Text] [Related]
34. [Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers]. Kanorskiĭ SG; Staritskiĭ AG; Bozhko AA Kardiologiia; 2005; 45(3):31-5. PubMed ID: 15821705 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Moss AJ; Zareba W; Hall WJ; Klein H; Wilber DJ; Cannom DS; Daubert JP; Higgins SL; Brown MW; Andrews ML; N Engl J Med; 2002 Mar; 346(12):877-83. PubMed ID: 11907286 [TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction. Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027 [TBL] [Abstract][Full Text] [Related]
37. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Cairns JA; Connolly SJ; Roberts R; Gent M Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198 [TBL] [Abstract][Full Text] [Related]
38. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. Iliceto S; Scrutinio D; Bruzzi P; D'Ambrosio G; Boni L; Di Biase M; Biasco G; Hugenholtz PG; Rizzon P J Am Coll Cardiol; 1995 Aug; 26(2):380-7. PubMed ID: 7608438 [TBL] [Abstract][Full Text] [Related]
39. Effects of high- and low-dose amiodarone on mortality, left ventricular remodeling, and hemodynamics in rats with experimental myocardial infarction. Hu K; Gaudron P; Ertl G J Cardiovasc Pharmacol; 2004 Dec; 44(6):627-30. PubMed ID: 15550779 [TBL] [Abstract][Full Text] [Related]
40. [Management of patients with risk of sudden death. The amiodarone example]. Djian J Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]